Background: Cannabis and its main psychoactive ingredient δ-9-tetrahydrocannibidiol (THC) can induce transient psychotic symptoms in healthy individuals and exacerbate them in those with established psychosis. However, not everyone experience these effects, suggesting that certain individuals are particularly susceptible. The neural basis of this sensitivity to the psychotomimetic effects of THC is unclear.

Methods: We investigated whether individuals who are sensitive to the psychotomimetic effects of THC (TP) under experimental conditions would show differential hippocampal activation compared with those who are not (NP). We studied 36 healthy males under identical conditions under the influence of placebo or THC (10 mg) given orally, on two separate occasions, in a pseudo-randomized, double-blind, repeated measures, within-subject, cross-over design, using psychopathological assessments and functional MRI while they performed a verbal learning task. They were classified into those who experienced transient psychotic symptoms (TP; n = 14) following THC administration and those who did not (NP; n = 22).

Results: Under placebo conditions, there was significantly greater engagement of the left hippocampus (p < 0.001) in the TP group compared with the NP group during verbal encoding, which survived leave-one-out analysis. The level of hippocampal activation was directly correlated (Spearman's ρ = 0.44, p = 0.008) with the severity of transient psychotic symptoms induced by THC. This difference was not present when we compared two subgroups from the same sample that were defined by sensitivity to anxiogenic effects of THC.

Conclusions: These results suggest that altered hippocampal activation during verbal encoding may serve as a marker of sensitivity to the acute psychotomimetic effects of THC.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0033291718000387DOI Listing

Publication Analysis

Top Keywords

psychotomimetic effects
16
transient psychotic
12
psychotic symptoms
12
effects thc
12
hippocampal activation
12
marker sensitivity
8
sensitivity psychotomimetic
8
verbal encoding
8
thc
7
effects
6

Similar Publications

3-Methylmethcathinone (3-MMC) is a designer drug that belongs to the group of synthetic cathinones. The compound has been scheduled in many jurisdictions because of public health concerns associated with excessive use. To date, there are no clinical studies that have evaluated the risk profile of 3-MMC in the recreational range of low to moderate doses.

View Article and Find Full Text PDF

Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice.

Neurotox Res

December 2024

Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

Chronic use of typical antipsychotics can lead to varying motor effects depending on the timing of analysis. Acute treatment typically induces hypokinesia, resembling parkinsonism, while repeated use can result in tardive dyskinesia, a hyperkinetic syndrome marked by involuntary orofacial movements, such as vacuous chewing movements in mice. Tardive dyskinesia is particularly concerning due to its potential irreversibility and associated motor discomfort.

View Article and Find Full Text PDF

Arketamine: a scoping review of its use in humans.

Eur Arch Psychiatry Clin Neurosci

December 2024

Laboratório de Neuropsicofarmacologia (LANP), Psychiatry Service, Hospital Universitário Professor Edgard Santos, Serviço de Psiquiatria, Universidade Federal da Bahia, Rua Dr. Augusto Viana, s/n-Canela, Salvador, Bahia, 40110-060, Brazil.

Article Synopsis
  • Arketamine (R-ketamine) has shown potential for prolonged antidepressant effects and better safety compared to esketamine (S-ketamine), though it has been less studied.
  • A review of 20 studies with 410 subjects indicated arketamine's effectiveness for pain management and depression, but many studies were small and informal.
  • While arketamine generally has a favorable safety profile, more substantial research is needed to better understand its therapeutic potential and proper clinical usage.
View Article and Find Full Text PDF

A comparative study of effects of DOM and lisuride on neuronal activity in nucleus accumbens of freely moving rats.

Eur J Pharmacol

January 2025

State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Key Laboratory of Neuropsychopharmacology, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, 100850, Beijing, China. Electronic address:

Article Synopsis
  • DOM and lisuride are both chemical compounds that act as partial agonists on 5-HT receptors, with DOM being hallucinogenic and lisuride lacking these properties.
  • A study using electrophysiological techniques on rats found that both drugs increased theta power and oscillation frequency but differed in their effects on medium spiny neurons and fast-spiking interneurons.
  • These findings highlight similarities that may help explain their effects on behavior, while also pointing out critical differences in neuronal activity that could account for the distinct hallucinogenic effects of DOM compared to the non-hallucinogenic lisuride.
View Article and Find Full Text PDF

Acute cannabidiol treatment reverses behavioral impairments induced by embryonic valproic acid exposure in male mice.

Pharmacol Biochem Behav

November 2024

Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address:

Cannabidiol (CBD), the major non-psychotomimetic compound of the Cannabis sativa plant, has shown promising effects in addressing various symptoms associated with autism spectrum disorder (ASD). This neurodevelopmental disorder typically impacts cognitive, behavioral, social communication, and motor skills domains. However, effective treatments for the wide range of symptoms associated with the disorder are limited and may trigger undesirable effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!